Connecting you to content on EBSCOhost

Works by Colombo, Matthew J.

Results: 5

1

B cells generated by B-1 development can progress to chronic lymphocytic leukemia.

Published in:

Annals of the New York Academy of Sciences, 2015, v. 1362, n. 1, p. 250, doi. 10.1111/nyas.12768

By:

Hayakawa, Kyoko;
Formica, Anthony M.;
Colombo, Matthew J.;
Ichikawa, Daiju;
Shinton, Susan A.;
Brill‐Dashoff, Joni;
Hardy, Richard R.

Publication type:

Article

2

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 7, p. 1336, doi. 10.1111/jdv.20553

By:

Armstrong, April W.;
Lebwohl, Mark;
Warren, Richard B.;
Sofen, Howard;
Morita, Akimichi;
Paul, Carle;
Papp, Kim A.;
Colombo, Matthew J.;
Scotto, Julie;
Vaile, John;
Zhuo, Joe;
Vritzali, Eleni;
Berger, Victoria;
Schroeder, Georgene;
Banerjee, Subhashis;
Thaçi, Diamant;
Strober, Bruce

Publication type:

Article

3

Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis.

Published in:

Dermatology & Therapy, 2024, v. 14, n. 7, p. 1891, doi. 10.1007/s13555-024-01201-4

By:

Armstrong, April W.;
Park, Sang Hee;
Patel, Vardhaman;
Nicolas, Pierre;
Wang, Wei-Jhih;
Colombo, Matthew J.;
Chirikov, Viktor

Publication type:

Article

4

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y

By:

Thaçi, Diamant;
Strober, Bruce;
Gordon, Kenneth B.;
Foley, Peter;
Gooderham, Melinda;
Morita, Akimichi;
Papp, Kim A.;
Puig, Lluís;
Menter, M. Alan;
Colombo, Matthew J.;
Elbez, Yedid;
Kisa, Renata M.;
Ye, June;
Napoli, Andrew A.;
Wei, Lan;
Banerjee, Subhashis;
Merola, Joseph F.;
Gottlieb, Alice B.

Publication type:

Article

5

Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials.

Published in:

JAMA Dermatology, 2025, v. 161, n. 1, p. 56, doi. 10.1001/jamadermatol.2024.4688

By:

Armstrong, April W.;
Lebwohl, Mark;
Warren, Richard B.;
Sofen, Howard;
Imafuku, Shinichi;
Ohtsuki, Mamitaro;
Spelman, Lynda;
Passeron, Thierry;
Papp, Kim A.;
Kisa, Renata M.;
Vaile, John;
Berger, Victoria;
Vritzali, Eleni;
Hoyt, Kim;
Colombo, Matthew J.;
Scotto, Julie;
Banerjee, Subhashis;
Strober, Bruce;
Thaçi, Diamant;
Blauvelt, Andrew

Publication type:

Article